Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei

Clinical trial NCT07341360 · RECRUITING

Trial details

NCT number: NCT07341360
Sponsor: Oslo University Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pseudomyxoma Peritonei

Start date: 2025-10-13
Primary completion: 2029-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.